- Strong Dollar Plays Global Stability Role: Geithner
- Gold Hits $1,121, Barrick Chief Says Selloff Possible
- Wall Street Pay Is Often too High: Bill Gates
- Morgan Stanley Gets Aggressive in Luring Brokers
- Foreclosures Fall Again But Improvement Likely Fleeting
- Highest State Foreclosure Rates
- Jobless, Wal-Mart to Drive Sentiment on Thursday
- Yuan Critics Want Obama to Keep Campaign Promise
- Pricier Beer Helps AB InBev Operating Profit
- What to Expect From Disney Earnings?
- HP's Shot Across Cisco's Bow
- USC Football Blog Leads All-Access Space
- Clowning Around At Work
- Ahead of Earnings Disney Restructures Studio
- Nov. 11: Unusual Volume Leaders
- 3 'Clear Sailing' Mid-Caps For Investors: Strategist
- Intimate Apparel Sales Heating Up: Maidenform CEO
- A Day On The USS Harry S. Truman
- Global recovery seen risked by higher oil prices
- Syngenta acquires 2 seed companies in California
- Peugeot Citroen raises 2009 forecasts
- Brazil economy to grow 9 pct in 4Q, official says
- Salzgitter in Q3 loss of euro67 million
- Repsol Q3 profits down by nearly half
- Warming drives off Cape Cod's namesake, other fish
- Estonia's economic output down by 15.3 pct in Q3
- Ida further slows harvest for Southern farmers
Text Size 
WHITEHOUSE STATION, N.J. - Merck & Co. is set to complete its $41 billion acquisition of Schering-Plough Corp. later Tuesday, creating the world's second-largest drugmaker, behind Pfizer Inc.
The companies expect the deal will close after the end of market trading Tuesday.
The completion comes after the U.S. Federal Trade Commission approved the deal Thursday. Regulators in Europe and elsewhere, and shareholders of both companies, have already approved it.
The two companies have been jointly selling the cholesterol drugs Vytorin and Zetia for years.
The deal adds allergy drugs Nasonex and Clarinex to Merck's Singulair and its diabetes pill Januvia. It also gives Merck animal and consumer health products, and a promising biotech division.
(CORRECTS to say deal will close later Tuesday.)
Print
Email
- Bernard and Ruth Madoff's personal possessions will be auctioned this weekend. Click ahead to see.
- US real estate prices have fallen dramatically, but some places are still doing well. See the best-performing zip codes this year.
- An Italian cashmere maker aims to make profits while creating ideal conditions for his workers.
- Just in time for the holidays, the Triumph company of Japan offers the latest innovation in women’s undergarments.
- The real result of health care reform will be bloated government and higher deficits, says Larry Kudlow.
- Vote and suggest your own, and remember--there's a fine line between a hero and a zero.
Data is a real-time snapshot *Data is delayed at least 15 minutes